Sex and Disease Regulate MHC I Expression in Human Lung Epithelial Cells

Major histocompatibility complex class I (MHC I) molecules present endogenous peptides to CD8+ T-cells for immunosurveillance of infections and cancers. Recent studies revealed unexpected heterogeneity in MHC I expression among cells of different lineages. While respiratory diseases rank among the leading causes of mortality, studies in mice showed that lung epithelial cells (LECs) express lower MHC I levels than all other tested cell types. The present study aimed to evaluate MHC I expression in human LECs from parenchymal explants using single-cell RNA sequencing (scRNA-seq) and immunostaining of primary human LECs. After confirming the low constitutive MHC I expression in human LECs, we observed a significant upregulation of MHC I across three chronic respiratory diseases: chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), and cystic fibrosis (CF). Additionally, we unveiled an unexpected sexual dimorphism in MHC I expression in both health and disease, with males exhibiting higher levels of MHC I under steady-state conditions. Gene expression analyses suggest that differential redox balance between sexes is instrumental in this dimorphism. Our study unveils the complex interplay between MHC I expression, sex, and respiratory diseases. Since, in other models, MHC I upregulation contributes to the development of immunopathologies, we propose that it might have a similar impact on chronic lung diseases.

NEW & NOTEWORTHY

This study shows that MHC I expression is very low in healthy LECs but escalates significantly in three chronic respiratory diseases, potentially contributing to disease progression. Furthermore, sex-specific divergences in LEC MHC I levels hint at distinct susceptibilities to chronic lung inflammation between males and females.